Study at a glance
What is the short answer?
Some laboratory experiments show that cells making active vitamin D can change responses in nearby cells. The result depends on the cells, their treatment and access to the starting vitamin D compound. Responding cells can also make active vitamin D themselves.
Who or what was studied?
Researchers studied human immune cells grown in the laboratory and specially altered mice. They did not test whether supplements improved health in people.
What changed the response?
Timing and the way cells were stimulated mattered. A protein that carries vitamin D compounds in blood limited some cell responses to the starting compound. Mouse experiments showed that similar blood hormone levels can occur despite changes in kidney-related metabolism and other body measurements.
What does this mean, and what remains uncertain?
The starting vitamin D compound supplied in blood, local production and breakdown must be considered together. A blood level cannot describe every tissue response. These studies do not establish activity in every tissue, a general health benefit or a personal dose. They did not measure how much hormone each human tissue makes or uses over time.
Read the full article below ↓Some cells can make active vitamin D and change responses in nearby cells in laboratory experiments. The result depends on the cells, how they were stimulated and access to the starting vitamin D compound. Mouse studies add information about local production and kidney control. These findings support local communication under the tested conditions. They do not show a health benefit from supplements in people. Paracrine Vitamin D Signalling: Full Study
How was communication between cells tested?
The studies distinguish 25-hydroxyvitamin D, the starting compound carried in blood, from calcitriol, the active vitamin D hormone. A cell may respond to active hormone supplied directly without being able to make enough from the starting compound. Finding an enzyme that performs this conversion is not the same as showing that hormone was made and changed a nearby cell.
Jeffery and colleagues transferred fluid from human dendritic cells to separately stimulated T cells. Both are immune-cell types. The responding T cells increased CTLA-4, a protein involved in controlling T-cell responses. Other tests supported conversion of the starting compound into active hormone. This supports communication from producing cells to other cells in those laboratory conditions. It did not trace every hormone molecule or measure a health benefit.
Villalba Lopez and colleagues studied macrophages, another immune-cell type. Macrophages prepared under different laboratory conditions made different amounts of active hormone and changed responses in T cells grown with them. These cell categories do not represent every macrophage in a living tissue. Other substances released by cells can affect their neighbours, so not every response to transferred fluid can be assigned to calcitriol alone.
What can change the response?
Vitamin D-binding protein carries vitamin D compounds in blood. Adding this protein limited several cell responses to the starting compound. Some macrophage cultures remained active at the tested concentration. However, the highest tested concentration was below the usual concentration in blood. The experiment did not show that they could overcome the usual amount of carrier binding in blood.
Kongsbak and colleagues found that stimulated T cells developed the ability to make active hormone over several days. Chauss and colleagues linked a particular T-cell response to local vitamin D processing. Responding cells can therefore contribute their own active hormone. This does not prove that all the hormone remains inside the cell that makes it. Vitamin D and Intracrine Activity explains that distinction.
How does this connect with the rest of the body?
Local activity depends on available starting material and the cells’ surroundings. Meyer and colleagues detected active vitamin D outside the kidney in specially altered mice. Lee and colleagues found similar blood active-hormone levels in kidney-altered mice and controls. In the more affected model, parathyroid hormone, which helps control blood calcium, was higher and bone density was lower.
Similar blood levels therefore did not mean that all body measurements were normal. Some hormone might still have been made in the kidney, other tissues might have made it, or slower breakdown might have helped maintain the level. The studies did not measure how much each route contributed. The two mouse papers involved connected researchers and methods, rather than separate teams repeating one identical experiment. Tissue-Specific Vitamin D Metabolism explains the tissue-metabolism setting, while Where Vitamin D Acts describes the wider locations of vitamin D action.
What remains uncertain?
Human cells in a dish and altered mice answer different questions from supplement trials in people. Timing, protein binding and how cells were stimulated all matter. The findings do not show activity in every tissue, how much hormone moves through each human tissue over time, a general health benefit or a personal supplement dose.
Scientific sources
Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. Jeffery LE, Wood AM, Qureshi OS, et al. Journal of immunology (Baltimore, Md. : 1950). 2012;189(11):5155-64. DOI: 10.4049/jimmunol.1200786.
Vitamin D-binding protein controls T cell responses to vitamin D. Kongsbak M, von Essen MR, Levring TB, et al. BMC immunology. 2014;15:35. DOI: 10.1186/s12865-014-0035-2.
Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses. Lopez DV, Al-Jaberi FAH, Woetmann A, et al. Frontiers in immunology. 2021;12:722806. DOI: 10.3389/fimmu.2021.722806.
Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Chauss D, Freiwald T, McGregor R, et al. Nature immunology. 2022;23(1):62-74. DOI: 10.1038/s41590-021-01080-3.
Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging. Meyer MB, Lee SM, Cichanski SR, et al. JCI insight. 2024;9(15). DOI: 10.1172/jci.insight.181763.
Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3. Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology. 2025;250:106734. DOI: 10.1016/j.jsbmb.2025.106734.
Related reading
Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging
Here, utilizing on-tissue chemical derivatization and matrix assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI), we investigated the distribution of 1,25(OH)2D3 and 25(OH)D3 in the kidney, liver, spleen, and thymus.
Original paper ↗Read more →Vitamin D-binding protein controls T cell responses to vitamin D
In vitro studies have shown that the active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), can regulate differentiation of CD4+ T cells by inhibiting Th1 and Th17 cell differentiation and promoting Th2 and Treg cell differentiation.
Original paper ↗Read more →Modulation of the Paracrine Kynurenic System in Bone as a New Regulator of Osteoblastogenesis and Bone Mineral Status in an Animal Model of Chronic Kidney Disease Treated with LP533401
This study aimed to establish if the inhibition of serotonin synthesis by LP533401 may affect the kynurenine pathway activity in bone tissue and its potential consequence with regard to osteogenesis and bone mineral status.
Original paper ↗Read more →Parathyroid histology in normocalcemic and hypercalcemic primary hyperparathyroidism with hypercalciuric renal stones
This study aimed to compare the histological features of NHPT and HPHPT parathyroid glands, but also rims of normal tissue, focusing on the expression of calcium-sensing receptor (CaSR), 1-α hydroxylase (CYP27B1), and vitamin D receptor (VDR).
Original paper ↗Read more →Anti-Inflammatory Effects of Vitamin D on Human Immune Cells in the Context of Bacterial Infection
Vitamin D induces a diverse range of biological effects, including important functions in bone health, calcium homeostasis and, more recently, on immune function.
Original paper ↗Read more →In Vivo Regulation of Signal Transduction Pathways by Vitamin D Stabilizes Homeostasis of Human Immune Cells and Counteracts Molecular Stress
Eight of the pathways show an approximately even contribution of up: and downregulated genes, suggesting that the actions of vitamin D stabilize homeostasis of the physiological processes driven by the respective signaling cascades.
Original paper ↗Read more →Paracrine Vitamin D Signalling: Full Study
Compare human-cell and mouse studies of paracrine vitamin D, precursor supply, carrier binding and renal feedback, including causal limits.
Read more →Vitamin D and Paracrine Signalling
Explore how vitamin D operates through paracrine signalling, enabling local, tissue-specific regulation within broader physiological systems.
Read more →Chemoresistant fibroblasts dictate neoadjuvant chemotherapeutic response of head and neck cancer via TGFα-EGFR paracrine signaling
Conventional chemotherapy targets malignant cells without evaluating counter protection from the tumor microenvironment that often causes treatment failure.
Original paper ↗Read more →Vitamin D Auto-/Paracrine System Is Involved in Modulation of Glucocorticoid-Induced Changes in Angiogenesis/Bone Remodeling Coupling
Osteoporosis is a devastating side effect of chronic glucocorticoid (GC) treatment.
Original paper ↗Read more →Vitamin D Induces Interleukin-1β Expression: Paracrine Macrophage Epithelial Signaling Controls M. tuberculosis Infection
The impact of IL-1β production was investigated in a novel model wherein infected macrophages were co-cultured with primary human small airway epithelial cells.
Original paper ↗Read more →A genome-wide association study identifies a possible role for cannabinoid signalling in the pathogenesis of diabetic kidney disease
Diabetic kidney disease (DKD), also known as diabetic nephropathy, is the leading cause of renal impairment and end-stage renal disease.
Original paper ↗Read more →Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease
Here, we examined the effects of Fgfr1: 3, αKlotho, or Fgfr1: 4 ablation specifically in the PG (conditional knockout, cKO).
Original paper ↗Read more →Bone Turnover in Patients with Chronic Kidney Disease Stage 5D and Healthy Controls: a Quantitative [18F]Fluoride PET Study
We compared optimized quantitative [18F]fluoride PET/CT methods to the reference standard with arterial input function (AIF) to identify a clinically accessible method for evaluation of bone turnover in patients with CKD.
Original paper ↗Read more →Effect of oral sodium bicarbonate on fibroblast growth factor-23 in patients with chronic kidney disease: a pilot study
The objective of this study is to evaluate the effect of oral sodium bicarbonate on circulating FGF23 levels in patients with CKD.
Original paper ↗Read more →Evaluation of Sarcopenia in Renal Transplant Recipients
The aim of the present study was to assess the prevalence of sarcopenia in renal transplant recipients (RTR) and to evaluate the demographic and metabolic risk factors associated with sarcopenia in these patients.
Original paper ↗Read more →Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients
Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software.
Original paper ↗Read more →Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis
As there is no consensus on the optimal treatment for post-kidney transplant recipients (KTRs), we aimed to evaluate the efficacy and safety of bisphosphonate and its combined therapies.
Original paper ↗Read more →The impact of a needs-oriented dental prophylaxis program on bacteremia after toothbrushing and systemic inflammation in children, adolescents, and young adults with chronic kidney disease
General prevalence of bacteremia after toothbrushing was 9.5% affecting 7 (26%) of the participants.
Original paper ↗Read more →Vitamin D and osteoporosis in chronic kidney disease
Osteoporotic fractures are common in patients with chronic kidney disease (CKD).
Original paper ↗Read more →Vitamin D receptor polymorphisms and bone health after kidney transplantation
We investigated the relationship between the polymorphisms of the vitamin D receptor ( VDR ) gene and bone diseases occurring after kidney transplantation.
Original paper ↗Read more →Original sources
Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses
Published in Jeffery LE, Wood AM, Qureshi OS, et al. Journal of immunology (Baltimore, Md. : 1950) (2012).
Publication details
Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. Jeffery LE, Wood AM, Qureshi OS, et al. Journal of immunology (Baltimore, Md. : 1950). 2012;189(11):5155-64. DOI: 10.4049/jimmunol.1200786.
Vitamin D-binding protein controls T cell responses to vitamin D
In vitro studies have shown that the active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), can regulate differentiation of CD4+ T cells by inhibiting Th1 and Th17 cell differentiation and promoting Th2 and Treg cell differentiation.
Publication details
Vitamin D-binding protein controls T cell responses to vitamin D. Kongsbak M, von Essen MR, Levring TB, et al. BMC immunology. 2014;15:35. DOI: 10.1186/s12865-014-0035-2.
Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses
Published in Lopez DV, Al-Jaberi FAH, Woetmann A, et al. Frontiers in immunology (2021).
Publication details
Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses. Lopez DV, Al-Jaberi FAH, Woetmann A, et al. Frontiers in immunology. 2021;12:722806. DOI: 10.3389/fimmu.2021.722806.
Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells
Published in Chauss D, Freiwald T, McGregor R, et al. Nature immunology (2022).
Publication details
Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Chauss D, Freiwald T, McGregor R, et al. Nature immunology. 2022;23(1):62-74. DOI: 10.1038/s41590-021-01080-3.
Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging
Here, utilizing on-tissue chemical derivatization and matrix assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI), we investigated the distribution of 1,25(OH)2D3 and 25(OH)D3 in the kidney, liver, spleen, and thymus.
Publication details
Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging. Meyer MB, Lee SM, Cichanski SR, et al. JCI insight. 2024;9(15). DOI: 10.1172/jci.insight.181763.
Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3
Published in Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology (2025).
Publication details
Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3. Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology. 2025;250:106734. DOI: 10.1016/j.jsbmb.2025.106734.